Other Information
−Removed: No directors or officers adopted , modified or terminated a Rule 10b5-1 trading arrangement during the fiscal quarter ended September 30, 2024.
+Added: No directors or officers adopted , modified or terminated a Rule 10b5-1 trading arrangement during the fiscal quarter ended March 31, 2025.
Exhibit Number Description
−Removed: Balchem Corporation Articles Supplementary (incorporated by reference to Exhibit 3.1 to the Form 8-K filed on September 20, 2024).
+Added: Balchem Corporation Executive Severance Policy (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on February 14, 2025).*
+Added: Form of Agreement, Balchem Corporation Restricted Stock Grant Agreement (filed herewith).*
+Added: Form of Agreement, Balchem Corporation Performance Share Unit Grant Agreement (filed herewith).*
+Added: Form of Agreement, Balchem Corporation Non-Employee Director Restricted Stock Grant Agreement (filed herewith).*
Certification of Chief Executive Officer pursuant to Rule 13a-14(a).
18 unchanged sentences
Chief Financial Officer
−Removed: October 25, 2024
+Added: April 24, 2025
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.